Objective: To determine: (a) whether the components of metabolic syndrome (MetS) cluster more frequently than predicted by chance alone and (b) whether increased risk for MetS is associated also with values of each component below, but close to the cutoff points defining MetS. Research design and methods: Anthropometrical and biochemical measurements were performed and a dietary questionnaire was filled-in in 1833 randomly selected non-diabetic subjects, 916 men and 917 women, 20-74 years old, in nine centres in five Mediterranean countries. The prevalence of MetS and of possible combinations of its individual components was measured. The expected frequencies of the above combinations were calculated according to the mathematical formula of probabilities. Results: The overall prevalence of MetS was 27.2%, but varied greatly among countries, from 5.8% in Algeria to 37.3% in Greece. The observed prevalence of each combination diagnostic of MetS was higher than the expected by chance. Thus, the observed overall prevalence of MetS was also higher than the expected, 27.2 vs 24.0%, P ¼ 0.03. Furthermore, for each individual component (except high-density lipoprotein), as values in the normal range, approached the cutoff point, the risk of having MetS (i.e. clustering of the other components) increased significantly (odds ratio 2.2-4.6, Po0.001). Conclusions: The MetS is not related to the Mediterranean type of diet and its prevalence varies greatly among five Mediterranean countries. The clustering of the components defining the MetS is not due to chance and moreover even 'high normal' levels of each component confer increased risk for the syndrome.
Introduction
The metabolic syndrome (MetS) is a complex disorder, which is considered as cardiovascular risk factor and is composed of multiple metabolic abnormalities, each one being a cardiovascular risk factor on its own. The first observation of the tendency of some metabolic abnormalities to be seen together in a patient has been published in the early 1920s (Kylin, 1923) . However, the syndrome has become widely known since Reaven described it as Syndrome X in 1988, claiming that glucose intolerance, hypertension and dyslipidemia cluster commonly in certain people, who are quite resistant to insulin-stimulated glucose uptake (Reaven, 1988) .
Since then, MetS has become very much a focus of interest. Its prevalence in an apparently healthy population in USA was found to be nearly 24% (Ford et al., 2002) and increased overtime (Ford et al., 2004) . Its etiology, that is, the underlying cause of MetS, is unknown. Although insulin resistance and visceral adiposity are proposed precursors (Meigs et al., 1997; Haffner et al., 1999) , the cause might be a more complex interaction between genetic and environmental factors (Grundy, 2004) . Several candidate genes are considered in the pathogenesis of MetS (Groop, 2000; Lee and Tsai, 2002) , whereas there is a proven association of the metabolic abnormalities of MetS with obesity and lack of exercise.
In some studies, MetS is associated with a threefold increased risk of coronary heart disease, myocardial infarction and stroke (Isomaa et al., 2001) , and a three-to fivefold increased risk of cardiovascular death (Haffner et al., 1992; Mykkanen et al., 1993) , even after adjustment for conventional risk factors (Lakka et al., 2002) .
The three main questions regarding MetS are: (a) whether the cardiovascular risk associated with MetS is greater than the sum of the risks associated with each individual risk factor, (b) whether the components of MetS cluster at a higher rate than that predicted by chance alone and (c) whether increased risk for MetS is associated also with values of each component below, but close to the cutoff points defining MetS. In most, but not all, studies MetS is associated with cardiovascular disease (CVD) risk that is not entirely accounted for by traditional risk scoring paradigms, thus this question remains still open (Golden et al., 2002; Klein et al., 2002; Alexander et al., 2003; Girman et al., 2004; Olijhoek et al., 2004; Stern et al., 2004; McNeill et al., 2005) . For the second and third questions little is known.
The aim of the present study was to assess the prevalence of MetS among non-diabetic subjects in the Mediterranean Basin to investigate whether the diagnostic constellation of disorders in these subjects exceeds rates predicted by chance and to investigate the risk for having MetS in subjects with values below, but close, the cutoff points defining the syndrome.
Subjects and methods
The study protocol has been described in detail elsewhere (Karamanos, 1996; Karamanos et al., 2002) . In brief, a total of 4254 subjects, 2090 non-diabetic and 2163 with type II diabetes were recruited in six countries, Algeria, Bulgaria, Egypt, Italy, Greece and Serbia-Montenegro. In the last centre, only diabetic subjects were studied. At least 150 nondiabetic subjects on a free diet, from a defined geographical region, were recruited in each centre. The subjects were randomly selected either from the electoral lists or other official record, according to the centre. The present analysis comprises 1833 non-diabetic subjects (916 men, 917 women), aged 20-74 years, for whom complete data were available.
Subjects were asked not to change their regular diet before the examination and were studied after an overnight (12-h) fast. A 12 ml venous blood sample was taken and the plasma was immediately separated and stored at À201C. All the samples were later shipped to the Central Laboratory (Diabetes Centre, Athens, Greece), on dry ice, where all the laboratory investigations were performed. Plasma glucose, cholesterol, triglycerides and high-density lipoprotein (HDL)-cholesterol were measured with the standard autoanalyzer methodology. The intra-assay coefficient of variation for glucose was 0.5%, cholesterol 0.6%, HDL 2.3% and triglycerides 0.6%. Interassay coefficient of variation for glucose was 1.2%, cholesterol 1.6%, HDL 4.8% and triglycerides 1.3%. Moreover, the effect of storage was tested by measuring aliquots of the same sample before and after storage for 3 months at À201C. The correlation coefficients between the two sets of values, before and after storage, were: glucose r ¼ 0.9964, cholesterol r ¼ 0.9981, HDL r ¼ 0.9771 and triglycerides r ¼ 0.9998, (Po0.001) (Karamanos, 1996) . A patient report form, comprising demographic data, medical and family history and smoking habits, was filledin. Anthropometric measurements comprised height without shoes, weight with light clothing, waist circumference (midway between the rib cage and the iliac crest) and blood pressure in the sitting position, after a 5-min rest (mean of two measurements).
A previously validated dietary questionnaire, comprising 78 questions, was filled-in by a trained examiner (dietician or nurse) and analysed according to a specially constructed computer program adjusted for data on local food specialties (Karamanos et al., 2002) .
Adherence to the 'traditional Mediterranean diet' was judged by Mediterranean-diet score X5. This score depends on the consumption of various foodstuffs, that is, fruits, vegetables, fish, etc. and ranges from 0 (minimal adherence to the traditional Mediterranean diet) to 9 (maximal adherence) (Trichopoulou et al., 1995 (Trichopoulou et al., , 2003 .
Ethics approval for the study was obtained in each individual country, by the appropriate committee. All subjects, who participated to the study, gave their informed consent.
Definition of the MetS
MetS was diagnosed by the National Cholesterol Education Program (NCEP) criteria, when three or more of the following characteristics cluster in the same person: (1) abdominal obesity: waist circumference 4102 cm in men and 488 cm in women, (2) hypertriglyceridaemia: X150 mg/dl, (3) low HDL-cholesterol: o40 mg/dl in men and o50 mg/dl in women, (4) high blood pressure: X130 mm Hg systolic and or X85 mm Hg diastolic or antihypertensive treatment and (5) high fasting glucose: X110 mg/dl (National Cholesterol Education Program (NCEP), 2001).
Statistical analysis
Categorical variables are presented as percentages and differences were evaluated by the w 2 test, Yates's correction or Fisher's exact test. A P-value of less than 0.05 was considered statistically significant. All tests were performed after age standardization, the whole non-diabetic population used as standard population. For continuous variables with normal distribution, Student's t-test was used and data are presented as means. Variables with skewed distribution were log-transformed. Analysis of variance was used for the evaluation of the differences among centres. The expected prevalence of the various diagnostic combinations of the five components of MetS was calculated as the product of the individual prevalence of each component in the population and compared with the observed prevalences using the w 2 test (Armitage, 1983) . As more than one diagnostic combination can be found in the same subject (three, four or five positive components), subjects with more than one combination were considered only once in the calculation of the expected number of subjects diagnosed with MetS, in the combination with the greatest number of positive components. For the comparison of the nutritional data between MetSpositive and MetS-negative subjects, adjustments for age, sex and total calories were made. To avoid multiplicity errors, all P-values were adjusted for multiple comparisons according to Bonferroni. All subjects with values below the diagnostic cutoff point for each individual component were divided into 3-5 groups. For waist circumference, triglycerides and glucose, the quintiles of distributions were used. The calculation for waist circumference was made separately in men and women. For variables with narrow distribution of values, that is, systolic and diastolic blood pressure and HDL-cholesterol, groups with arbitrary cutoff points were created. The relative risk of having MetS between groups was calculated from 2 Â 2 tables.
The statistical analysis was performed with the Statistical Package for the Social Sciences for Windows (SPSS) version 11.5 (Chicago, IL, USA).
Results
The characteristics of the subjects and the age-standardized prevalence of MetS are provided by country and gender (Table 1 ). There were significant differences in age among centres. Moreover, the prevalence of MetS increased with age, being 10.5% in 20-29 years age group, 16.8% in 30-44 years, 32.7% in 45-59 years and 46.1% in 60-74 years age group (data not shown). Thus, age-standardization was used for further analysis. The prevalence of MetS in the population studied was 27.2% but varied greatly among centres, from 5.8% in Algeria to 20.6% in Egypt and 37.3% in Greece. No differences between sexes were noted in the population as a whole and in most centres with two exceptions.
Among the components of MetS, abnormal HDL was the more frequently observed, followed by blood pressure, waist circumference and triglycerides, both in subjects with and without MetS, being, as expected, more prevalent in subjects with MetS. Abnormal glucose was observed in 14% of MetSpositive subjects, in only 2.2% of MetS-negative subjects and in 5.5% of the population as a whole, being the less frequently observed characteristic of MetS ( Table 2) .
The expected prevalences (mathematically computed) of the various combinations of the individual components, which set the diagnosis of MetS, are provided on the left column of Table 3 . The corresponding observed prevalences are also shown and most of them are significantly higher than the expected. The most frequently observed combinations are waist, HDL and blood pressure, 14.5%; and triglyceride, HDL and blood pressure, 12.4%. The rest of the combinations were observed in less than 10% of the population.
As subjects in the groups having four or five components of MetS belong also to groups having three components and in order to consider each subject only once, the expected prevalence of each combination of three components and the corresponding number of subjects with it were calculated by subtracting the prevalence of combinations of more components (subtraction of percentages and relevant calculation of subjects). The result is shown together with the observed corresponding values (Table 3 ). The observed number of subjects having MetS with a combination of three components was 370, with a combination of four components 116 and of all five components 13 subjects. Therefore, 499 subjects had MetS (observed) and 441 should have MetS (expected). Thus, in the population studied, significantly more subjects had MetS than expected, if the components of MetS clustered only by chance, P ¼ 0.03.
We examined the possibility that the distribution of the values below the diagnostic cutoff points of each component could be related with clustering of the other components (Table 4) . Subjects in the fourth and fifth quintile of waist values distribution below the cutoff point compared to the first quintile had, after age-standardization, 3.3 and 2.5 greater risk, respectively, for having MetS (i.e. for having three of the other components in the diagnostic range).
The same was observed for the quintiles of triglycerides and glucose. Because of the narrow distribution of values of systolic and diastolic blood pressure and HDL-cholesterol, groups with arbitrary cutoff points were created. Subjects with systolic blood pressure higher than 110 mm Hg had at least 2 times greater risk for having MetS (Table 4) . Moreover, subjects with diastolic blood pressure of 80 mm Hg or more
Clustering of MetS components
A Thanopoulou et al had 4.6 times greater risk for having MetS. No such phenomenon was observed for HDL. The qualitative composition of the diet differed between MetS-positive and MetS-negative subjects (Table 5) . Carbohydrates and proteins contributed less, whereas fat contributed more to the daily energy intake of MetS-positive subjects. Small differences were found for three of the nine components of the Mediterranean diet score. However, no better overall adherence to the classically described 'Mediterranean type of diet' as judged by the above score, was observed in subjects without MetS.
Discussion
The overall prevalence of MetS in the Mediterranean countries studied is 27.2% and is quite similar to that found in the National Health and Nutrition Examination Survey (NHANES) 1999-2000 study in USA (Ford et al., 2004) .
Comparison of the prevalence of MetS between studies is difficult, as modified criteria are frequently used and, most importantly, sex and age standardization is indispensable, which is not easily done between published studies. The very low prevalence of MetS in a Finnish study (below 15%) (Lakka Clustering of MetS components A Thanopoulou et al et al., 2002) is probably due both to modified criteria and population selection (only middle-aged men). However, the great differences in the prevalence of MetS among the Mediterranean countries are real, as the same diagnostic criteria were used and meticulous sex and age standardization were done. These variations may reflect ethnic, racial, socioeconomic or other differences among countries or populations and such differences have been already documented in other studies (Haffner et al., 1996; Cameron et al., 2004) . Since the closure of the database of the present study, IDF came up with new criteria for the diagnosis of MetS. These differ greatly from those of NCEP, as they consider as prerequisite the presence of central obesity, with much lower cutoff points. By these newly proposed criteria, the prevalence of MetS increases considerably, especially in the older age groups (Athyros et al., 2005) . Analysis of our data by these criteria showed a significant increase of the prevalence of MetS, from 27.2 to 35.7%, which was also observed in the individual countries. The value of the new IDF criteria remains to be proven.
The differences in the prevalence of MetS among countries are, more or less, in parallel with the differences in CVD Waist 1 1.5 (0.8-3.0) 1.3 (0.6-2.6) 3.3*** (1.8-5.9) 2.5*** (1.3-4.8) Triglycerides 1 1.0 (0.5-2.0) 1.8 (1.0-3.2) 2.7*** (1.5-4.5) 3.1*** (1.8-5.2) Glucose 1 1.3 (0.9-1.8) 1.3 (0.9-1.9) 2.8*** (1.9-4.0) 2.3*** (1.6-3.4) 1st G 2nd G 3rd G Systolic blood pressure 1 2.8*** (1.6-5.1) 2.2** (1.3-3.8) Diastolic blood pressure 1 2.3 (0.9-5.7) 4.6*** (2.0-9.7) HDL 1 0.9 (0.4-1.8) 0.7 (0.3-1.7)
Abbreviations: CI, confidence interval; OR, odds ratio; HDL, high-density lipoprotein. Q ¼ Quintiles of waist, triglycerides, glucose below the cut-off points. *Po0.05, **Po0.01, ***Po0.001 compared to Q1 or to G1. mortality and the prevalence of diabetes in these countries, as documented from WHO reports (World Data Table) . Thus, the prevalence of diabetes increases from 2.6% in Algeria to 7.2% in Egypt, 7.7% in Bulgaria, 9.3% in Italy and 10.3% in Greece, following in a way, the corresponding increase in MetS prevalence. Furthermore, the mortality rates per 100 000 population, again according to the WHO data (World Data Table) , follow more or less the fluctuations in the prevalence of both diabetes and MetS (being 99.70 in Algeria, 197.00 in Egypt, 591.65 in Bulgaria, 281.83 in Italy and 360.25 in Greece), with the exception of Bulgaria, where the mortality is disappointingly high. The above epidemiologic observations showing parallel changes in the prevalence of MetS, diabetes and CVD mortality cannot be considered as evidence of etiological associations among the three parameters, not only because the results do not derive from the same study, but also because many confounders can obscure the association; however, they deserve further investigation.
On the other hand, the prevalence of the individual components of MetS in the present study was different than that found in the NHANES 1999-2000 study (Ford et al., 2004) . Such variations between studies may reflect real differences, because of ethnic, socioeconomic or other parameters but also they may reflect methodological differences, as is the case for waist measurement, which in some studies is made at the level of iliac crest (Ford et al., 2004) and in others midway between the iliac crest and the lower ribs (Isomaa et al., 2001; Palaniappan et al., 2004) , whereas in other studies surrogate markers, such as body mass index (BMI) are used (Malik et al., 2004) .
The expected prevalence of all possible combinations of the individual components diagnostic of MetS, calculated as the product of the individual prevalences of each component, is significantly lower than the actually observed. Consequently, the number of subjects found to have MetS is significantly higher than the theoretically expected, according to the calculations. Great attention has been paid to the calculation of the subjects expected to have MetS, so that those having more than one diagnostic combination (three, four or five components) be counted only once. Our findings confirm the hypothesis that clustering of the components of MetS is not due to chance, but reflects the action of an underlying force (insulin resistance?) driving the components together. Although it was supposed that the components of MetS co-occur in an individual more often than might be expected by chance, this was not supported by appropriate scientific evidence even in the most recent publications (Eckel et al., 2005) . This kind of analysis is performed for the first time to our knowledge for the components of MetS by NCEP definition. However, clustering beyond chance has been already shown for other risk factor combinations (Schmidt et al., 1996; Wilson et al., 1999) . An analysis of the data of subjects participating in the Atherosclerosis Risk in Communities Study has shown that clustering of two risk factors (HDL, hyperuricemia, diabetes, etc.) occurred 1.1-2.4 times more frequently than expected and that it was related to serum insulin, waist-to-hip ratio and BMI quintiles. Some of the parameters studied are now considered components of MetS. However, clustering of three or more components of MetS, which is the hallmark of the diagnosis of MetS, was not considered in that study (Schmidt et al., 1996) . Another study examined the clustering of six risk factors, some of which are components of MetS, and found beyond chance clustering. However, the cutoff points for abnormality were the extreme quintiles of each risk factor distribution and not the cutoff points defined by NCEP (Wilson et al., 1999) . Thus, the present study remains the only one examining not just clustering of various risk factors but the clustering of components leading to the diagnosis of MetS as such.
As the various components of MetS are continuous variables, the risk they confer should increase in a continuous manner rather than having a threshold. We thus hypothesized that if the common denominator of MetS drives in parallel all components towards abnormality, then values below the cutoff point of each component, but close to it, could have prognostic significance for the clustering of the other components. Our data support this hypothesis as subjects with values close to the cutoff point had more than double risk for having MetS, that is, for having three or all four of the other components in the 'abnormal' range. The only component for which no such correlation was found was HDL. These findings suggest that reconsideration of the cutoff points is probably justified and also support the recent proposition for lowering of the cutoff point for glucose ; American Diabetes Association, 2005). However, this requires well-planned prospective studies with carefully chosen end points, in order to be able to choose each individual cutoff point according to the best sensitivity, specificity and predictive value. The small differences found in the qualitative composition of the diet are not in line with those of a recent study , which documented increased risk of MetS with higher carbohydrate and lower fiber consumption. In the present study, increased fat contribution to the energy intake, rather than increased carbohydrates, seems to be associated with MetS. However, the differences, although statistically significant, are small, and thus of ambiguous biological significance. Moreover, MetS positive and negative subjects did not differ in the Mediterranean diet score, the best index of adherence to a Mediterranean type of diet, which is considered the healthiest and is also associated both with decreased cardiovascular and overall mortality (Kromhout et al., 1989; Trichopoulou et al., 1995 Trichopoulou et al., , 2003 Trichopoulou et al., , 2005 . Thus, dietary habits, assessed cross-sectionally, are not associated with MetS; however, this finding does not exclude possible longitudinal effects of the diet. Thus, for the moment, the relation of MetS with the qualitative composition of the diet remains controversial.
In conclusion, the present study reveals great differences in the prevalence of MetS among five Mediterranean countries, but it was not scheduled to also investigate the causes of these differences. Cultural, genetic, educational and socioeconomic parameters may contribute to these differences, whereas there is no strong evidence for the effect of the qualitative composition of the diet or the Mediterranean type of diet. This study, for the first time to our knowledge, provides epidemiological evidence that the clustering of the components of MetS in the same person occurs more frequently than expected only by chance, supporting the view that a driving force, presumably insulin resistance, brings the components together. Moreover, we present data showing that values below, but close to the cutoff point of each individual component of MetS are associated with increased risk for MetS and presumably CVD, suggesting that reconsideration of the cutoff points may be warranted.
